Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...
In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...
Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules de...
Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Gr...
Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and fa...
Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company, a leader of specialty pharmaceutical pro...
Tokyo based AGC Inc. has announced on March 4 the completion of its acquisition of Spain's synthetic...
Thermo Fisher Scientific recently announced that the Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory a...
CAC Corporation has signed a partnership agreement with rfxcel Corporation in the pharmaceutical traceability field...
AbbVie and Eisai have announced that they have received approval for an additional indication of HUMIRA®, a fully hu...
The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of ...
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...
Generex Biotechnology has announced that the company’s subsidiary Regentys Corporation, a clinical stage regenerat...
KCI, an Acelity Company, recently announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan...
Fujitsu has announced the development of Fujitsu Healthcare Solution Healthcare Personal service Platform, a platform-as...
Eisai Co., Ltd. has announced that it has submitted an application to the European Medicines Agency (EMA) for its in-hou...
Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...
Seattle Genetics, Inc. has announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval fro...
